Clinical Trial
Journal Article
Add like
Add dislike
Add to saved papers

Rehabilitation time after simultaneous bilateral photorefractive keratectomy for low to moderate myopia.

PURPOSE: To evaluate the visual acuity rehabilitation time after simultaneous bilateral photorefractive keratectomy (PRK) using a flying small spot laser.

SETTING: Eye Tech Medical Laser, Tel Aviv, Israel.

METHODS: In this prospective interventional nonrandomized clinical trial, 42 consecutive eyes (21 patients) with myopia ranging from -0.75 to -5.50 diopters (D) (mean -2.75 D +/- 1.18 [SD]) and astigmatism up to -2.75 D (mean -0.64 +/- 0.55 D) were treated with bilateral simultaneous PRK using the ESIRIS excimer laser (Schwind). Main outcome measures were uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), and manifest refraction up to 12 weeks after surgery. Both eyes of each patient were examined at the same follow-up after initial treatment.

RESULTS: Within 2 weeks and 1 month of the laser procedure, the UCVA was at least 20/40 in 1 eye in 85.7% of patients (18 patients) and 100% of patients (21 patients), respectively. After 2 weeks, UCVA was at least 20/20, 20/25, and 20/40 in 7.1%, 40.5%, and 80.9% of eyes. The final mean manifest spherical equivalent 12 weeks post laser treatment was -0.10 +/- 0.26 D, with a mean sphere of +0.02 +/- 0.22 D and a mean cylinder of -0.24 +/- 0.37 D. No eye had a BCVA loss during the follow-up.

CONCLUSION: Simultaneous bilateral PRK using a flying small spot excimer laser for low to moderate myopia allowed most patients to return to most daily tasks in a couple of weeks without compromising safety.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app